Since angiogenesis is the most prominent feature of tumor growth, and since we have previously shown that SEPHS1 deficiency inhibits tumor-cell malignancy [11], targeted removal of SEPHS1 in endothelial cells may provide a potential new measure for antitumor therapy. Here, SEPHS1 is linked to neoplasm.